CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr | ₹24,837 Cr | ₹23,423 Cr |
What is the latest Total Liabilities ratio of CIPLA ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹32,130 Cr |
Mar2023 | ₹29,007 Cr |
Mar2022 | ₹26,652 Cr |
Mar2021 | ₹24,837 Cr |
Mar2020 | ₹23,423 Cr |
How is Total Liabilities of CIPLA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹32,130 Cr | 10.77 | |
Mar2023 | ₹29,007 Cr | 8.83 | |
Mar2022 | ₹26,652 Cr | 7.31 | |
Mar2021 | ₹24,837 Cr | 6.04 | |
Mar2020 | ₹23,423 Cr | - |
Compare Total Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹116,661.9 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
MANKIND PHARMA | ₹101,358.0 Cr | 2.4% | 7.1% | 3.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -4.4% |
0.2% |
-1.7% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses